Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 5, 2003
Analysis of interleukin-1alpha (IL-1alpha) and interleukin-8 (IL-8) expression and release in in vitro reconstructed human epidermis for the prediction of in vivo skin irritation and/or sensitizationA Coquette, N Berna, A Vandenbosch, et al.
Clinical Hemorheology and Microcirculation|March 31, 2015
Preparation and characterizations of EGDE crosslinked chitosan electrospun membranesA Aqil, V T Tchemtchoua, A Colige, et al.
Archives of Dermatological Research|September 7, 2004
A simple reconstructed human epidermis: preparation of the culture model and utilization in in vitro studiesY Poumay, F Dupont, S Marcoux, et al.
The Journal of Investigative Dermatology|March 25, 2000
Differentiation-dependent alternative splicing and expression of the extracellular matrix protein 1 gene in human keratinocytesP Smits, Y Poumay, M Karperien, et al.
European Journal of Histochemistry : EJH|August 1, 2007
Immunogold silver staining associated with epi-fluorescence for cucumber mosaic virus localisation on semi-thin sections of banana tissuesB Helliot, B Panis, J P Busogoro, et al.
Archives of Biochemistry and Biophysics|April 7, 1999
Human epidermal keratinocytes upregulate expression of the prolactin receptor after the onset of terminal differentiation, but do not respond to prolactinY Poumay, G Jolivet, M R Pittelkow, et al.
The British Journal of Dermatology|August 23, 2007
Functional redundancy of extracellular matrix protein 1 in epidermal differentiationS Sercu, Y Poumay, F Herphelin, et al.
Bioscience Reports|December 1, 1992
Processing and characterization of the low density lipoprotein receptor in the human colonic carcinoma cell subclone HT29-18: a potential pathway for delivering therapeutic drugs and genesJ C Mazière, C Mazière, S Emami, et al.
Skin Health and Disease|June 6, 2022
Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disordersJ G S Veit, Y Poumay, D Mendes, et al.
Pageof 3